Lung Cancer Market - Trends Forecast Till 2028

Market Overview

The global lung cancer market is anticipated to reach USD 50.14 billion by 2020 growing at a CAGR of 12.4% during the forecasting period, 2020-2028. Lung cancer is an uncontrolled growth of abnormal cells either in the single lung or both the lungs and these abnormal cells do not carry out the functions of normal lung cells and do not develop into healthy lung tissue. Factors such as the rising rate of lung cancer patients globally and rising smoking & air pollution globally leading to cause lung cancer are some of the major drivers for the lung cancer market

Key Findings

Global lung cancer market is segmented into drugs, phase, test, surgery procedures, therapy, end-user, and geography.

Drugs segment is segmented into Non-Small Cell Lung Cancer Drugs and Small Cell Lung Cancer Drugs. Small Cell Lung Cancer Drugs are further segmented into Angiogenesis Inhibitor, Epidermal Growth Factor Receptor Blocker, Kinase Inhibitor, Microtubule Stabilizer, Folate Antimetabolites, PD-1/ PD-L1 Inhibitor. Small Cell Lung Cancer Drugs is further segmented into Doxorubicin Hydrochloride, Doxorubicin Hydrochloride, Etopophos (Etoposide Phosphate), Etoposide, Hycamtin (Topotecan Hydrochloride), Mechlorethamine Hydrochloride, Methotrexate, Mustargen (Mechlorethamine Hydrochloride), Nivolumab, Opdivo (Nivolumab), Trexall (Methotrexate), Topotecan Hydrochloride and Everolimus.

Phase segment is segmented into Phase I, Phase II, Phase III, and Phase IV

Test segment is segmented into Imaging Tests, Sputum Cytology, Biopsy, Others. A biopsy is further segmented into Bronchoscopy and Mediastinoscopy.

Surgery Procedures segment is segmented into Segmental Resection, Wedge Resection, Lobectomy, Pneumonectomy, Video-Assisted Thoracoscopic Surgery, Thoracic Surgery, and Others

Therapy segment is segmented into Targeted Therapy, Radiation Therapy, Chemotherapy, Immunotherapy, Chemoradiotherapy, Stereotactic Radiation Therapy, Photodynamic Therapy, and Others

End Users segment is segmented into Oncology Centers, Hospitals, Specialty Centers, Academic Research Institutes and Laboratories and Others

Geographically, the global lung cancer market is sub-segmented into North America, Europe, Asia-Pacific, Middle East and Africa and South America and insights are provided for each region and major countries within the regions 

Regional Analysis

North America region is the largest contributor to the lung cancer market in the forecast period 2020-2028 and the Asia-Pacific region is expected to grow with the highest CAGR during the forecast period 2020-2028.

Competitive Landscape

Key players in the global lung cancer market are Kindred Healthcare, National Lung cancer, and Palliative Care Organization, Alzheimer’s Association, Benton Lung cancer Services, Oklahoma Lung cancer Care, New Hampshire Lung cancer and Palliative Care Organization, Dierksen Lung cancer, Covenant Care, Chatham-Kent Lung cancer, PruittHealth, Fairview Health Services and among others

Recent Developments

The companies have come up with various promotional activities in from of launch, investment, acquisition, and other, for instance:

• In 2018, Loxo Oncology has received a breakthrough therapy designation from the FDA for its treatment of patients with RET fusion-positive non&ndash small cell lung cancer (NSCLC) or RET-mutant medullary thyroid cancer (MTC)
• In 2018, researchers at the Indian Institute of Technology, Bombay have announced a newly developed platform that can help in the detection of lung cancer from breath. 

Hence, tremendous progress has been made over the last decade, and yet a lot more to come in recent years.

Reasons to Acquire

• Increase your understanding of the market for identifying the best and suitable strategies and decisions on the basis of sales or revenue fluctuations in terms of volume and value, distribution chain analysis, market trends, and factors
• Gain authentic and granular data access for the lung cancer market so as to understand the trends and the factors involved in changing market situations
• Qualitative and quantitative data utilization to discover arrays of future growth from the market trends of leaders to market visionaries and then recognize the significant areas to compete in the future
• In-depth analysis of the changing trends of the market by visualizing the historic and forecast year growth patterns

Report Scope